EGFR L858R

specific

A change in the amino acid residue at position 858 in the epidermal growth factor receptor protein where leucine has been replaced by arginine.

18

Centers

12

Active Trials

$2M

Cancer Funding

Top Centers for EGFR L858R(18)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
58.3
2
NCI Comprehensive
Active Research Program
58.3
3
NCI Comprehensive
Active Research Program
58.3
4
NCI Comprehensive
Active Research Program
58.3
5
NCI Comprehensive
Active Research Program
58.3
6
NCI Comprehensive
Active Research Program
58.3
7
NCI Comprehensive
Active Research Program
58.3
8
NCI Comprehensive
Active Research Program
58.3
9
Active Research Program
58.3
10
NCI Comprehensive
Active Research Program
58.3
11
Active Research Program
58.3
12
Active Research Program
58.3
13
NCI Clinical
Active Research Program
54.3
14
NCI Comprehensive
Active Research Program
52.4
1535.8
16
NCI Comprehensive
35.8
17
Cedars-Sinai CancerLos Angeles, CA
35.8
1835.8

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →